Skip to content

Study and analyze changes in metabolites of acute lung injury and screen and identify diagnostic biomarkers for acute lung injury

Metabolomics based mass spectrometry detection of human clinical specimens for predicting acute lung injury (ALI) in patients: a prospective multicenter observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081235
Enrollment
Unknown
Registered
2024-02-27
Start date
2023-10-11
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung injury

Interventions

Sponsors

Affiliated Hospital of Yangzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age range from 18 to 80 years old, regardless of gender; (2) Lung injury factors: severe lung infection, inhalation of stomach contents, Pulmonary contusion, inhalation of toxic gases, drowning, oxygen poisoning, severe infection, severe non Chest injury, acute severe pancreatitis, massive blood transfusion, extracorporeal circulation, disseminated intravascular coagulation, etc; (3) Having independent consciousness and the ability to make independent judgments; (4) The patient or their family members are aware of this study and have signed a consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who are unable to understand, tolerate, or cooperate with clinical specimen collection; (2) Accompanying patients with mental illness; (3) Patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Incidence of lung injury;metabolomics;

Countries

China

Contacts

Public ContactLu Guotao

Affiliated Hospital of Yangzhou University

gtlu@yzu.edu.cn+86 157 0527 1680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026